Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Rituximab dose-dependent infection risk in rheumatoid arthritis is not mediated through circulating immunoglobulins, neutrophils or B cells.
Rheumatology (Oxford). 2022 Dec 23;62(1):330-334. doi: 10.1093/rheumatology/keac318.
Rheumatology (Oxford). 2022.
PMID: 35686851
Identification of Risk Factors for COVID-19 Hospitalization in Patients With Anti-Rheumatic Drugs: Results From a Multicenter Nested Case Control Study.
Opdam MAA, Benoy S, Verhoef LM, Van Bijnen S, Lamers-Karnebeek F, Traksel RAM, Vos P, den Broeder AA, Broen J.
Opdam MAA, et al.
Clin Pharmacol Ther. 2022 May;111(5):1061-1065. doi: 10.1002/cpt.2551. Epub 2022 Feb 23.
Clin Pharmacol Ther. 2022.
PMID: 35143039
Free PMC article.
Item in Clipboard
Exploring the perspective of patients with immune-mediated inflammatory diseases and care providers on the use of immunomodulatory drugs in infections: an interview study.
Opdam MAA, Vriezekolk JE, Broen J, den Broeder AA, Verhoef LM.
Opdam MAA, et al.
Rheumatol Adv Pract. 2023 Jan 11;7(1):rkad003. doi: 10.1093/rap/rkad003. eCollection 2023.
Rheumatol Adv Pract. 2023.
PMID: 36685994
Free PMC article.
Item in Clipboard
Hypogammaglobulinemia in rheumatoid arthritis patients on rituximab: prevalence and risk factors.
Opdam MAA, Campisi LM, de Leijer JH, Ten Cate D, den Broeder AA.
Opdam MAA, et al.
Rheumatology (Oxford). 2024 Jan 4;63(1):e1-e2. doi: 10.1093/rheumatology/kead326.
Rheumatology (Oxford). 2024.
PMID: 37410082
No abstract available.
Item in Clipboard
Therapy with JAK inhibitors or bDMARDs and the risk of cardiovascular events in the Dutch rheumatoid arthritis population.
Popa CD, Opdam MAA, den Broeder N, van Ballegooijen H, Mulder K, van de Wiel KM, van Herwaarden N, Wientjes MHM, den Broeder AA.
Popa CD, et al. Among authors: opdam maa.
Rheumatology (Oxford). 2023 Oct 5:kead531. doi: 10.1093/rheumatology/kead531. Online ahead of print.
Rheumatology (Oxford). 2023.
PMID: 37796830
Item in Clipboard
Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs.
Opdam MAA, Broeder ND, van den Bemt BJF, Mulder K, van de Wiel KM, van Ballegooijen H, van Crevel R, den Broeder AA.
Opdam MAA, et al.
Clin Rheumatol. 2024 Jun;43(6):2133-2138. doi: 10.1007/s10067-024-06980-x. Epub 2024 May 4.
Clin Rheumatol. 2024.
PMID: 38703283
Item in Clipboard
Infection incidence, timing and dose dependency in rheumatoid arthritis patients treated with rituximab: a retrospective cohort study.
Veeken LD, Opdam MAA, Verhoef LM, Popa C, van Crevel R, den Broeder AA.
Veeken LD, et al. Among authors: opdam maa.
Rheumatology (Oxford). 2024 May 2;63(5):1246-1250. doi: 10.1093/rheumatology/kead328.
Rheumatology (Oxford). 2024.
PMID: 37410085
Item in Clipboard
Cite
Cite